Finance

Results: 35593-35604 of 43601

PR Newswire associated0

Breaking Ground in Innovation: SUNLU FilaDryer S4 Shines in the Market

PR Newswire associated0

Acquisition of Woven Group, accelerates iCXperience, the UK's largest Privately Owned Call Centre Group towards £100m Turnover

Innodata Withdraws Proposal to Acquire Appen

Alimentaria & HOSTELCO 2024 grows and faces its most international edition ever

JA Solar Signs MOUs with Three Leading Pakistani Enterprises for Supply of 600MW n-type PV Modules

Wind Point Partners Closes Fund X at $2.3 Billion Hard Cap

(Graphic: Business Wire)

Options Technology Achieves Microsoft Cloud Security Specialization, Solidifying Commitment to Excellence in Security Solutions

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

PR Newswire associated0

As phase I of 511MW project is connected to grid, TrinaTracker's Vanguard 1P makes Uzbekistan greener

PR Newswire associated0

JINHAN FAIR - Trade Show You Can't Miss in 2024 to Meet the Home & Gift Trends Ahead

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation